World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
117
Citations
47840
World Ranking
4223
National Ranking
2312

Research.com Recognitions

  • Member of the Association of American Physicians
  • Member of the Association of American Physicians

Overview

Jeffrey B. Kopp is affiliated with the National Institutes of Health in the United States. Their research primarily focuses on medicine, with a significant volume of work dedicated to nephrology, molecular biology, genetics, rheumatology, and immunology. The scientist has contributed extensively to the study of renal diseases and glomerulopathies, chronic kidney disease and diabetes, renal and related cancers, chronic lymphocytic leukemia research, systemic lupus erythematosus research, single-cell and spatial transcriptomics, and pregnancy and preeclampsia studies.

Their publication record includes several notable papers such as:

  • Podocytopathies, 2020, Nature Reviews Disease Primers
  • Development and evaluation of deep learning-based segmentation of histologic structures in the kidney cortex with multiple histologic stains, 2020, Kidney International
  • Genetics in chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference, 2022, Kidney International
  • COVID-19-Associated Collapsing Glomerulopathy: An Emerging Entity, 2020, Kidney International Reports
  • The key role of NLRP3 and STING in APOL1-associated podocytopathy, 2021, Journal of Clinical Investigation

Jeffrey B. Kopp has collaborated frequently with a number of coauthors, including Cheryl A. Winkler, Teruhiko Yoshida, Avi Z. Rosenberg, Khun Zaw Latt, and Shashi Shrivastav. The volume of these collaborations is notable, with each coauthor having contributed to multiple publications alongside Kopp.

The scientist's work has been published in various specialized venues. The most frequent publication venues include:

  • Journal of the American Society of Nephrology
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Kidney International
  • UNC Libraries
  • American Journal of Kidney Diseases

Research undertaken by Jeffrey B. Kopp spans key areas in biochemistry, genetics, and molecular biology, with a focus on clinical and laboratory investigations related to kidney diseases. The range of main fields and subfields shows a broad approach towards understanding mechanisms at molecular and immunological levels as well as clinical manifestations in nephrology.

The scientist holds a membership in the Association of American Physicians, reflecting a recognized position within the medical scientific community.

Best Publications

  • Association of trypanolytic ApoL1 variants with kidney disease in African Americans.

    Giulio Genovese;Giulio Genovese;David J. Friedman;Michael D. Ross;Laurence Lecordier

  • VEGF inhibition and renal thrombotic microangiopathy.

    Vera Eremina;J. Ashley Jefferson;Jolanta Kowalewska;Howard Hochster

  • Enzyme replacement therapy in Fabry disease: a randomized controlled trial.

    Raphael Schiffmann;Jeffrey B. Kopp;Howard A. Austin;Sharda Sabnis

  • Identification of renox, an NAD(P)H oxidase in kidney.

    Miklós Geiszt;Jeffrey B. Kopp;Péter Várnai;Thomas L. Leto

  • Hepatic expression of mature transforming growth factor beta 1 in transgenic mice results in multiple tissue lesions.

    Nancy Sanderson;Valentina Factor;Peter Nagy;Jeffrey Kopp

  • APOL1 Genetic Variants in Focal Segmental Glomerulosclerosis and HIV-Associated Nephropathy

    Jeffrey B. Kopp;George W. Nelson;Karmini Sampath;Randall C. Johnson;Randall C. Johnson

  • TGF-β and fibrosis

    Mary H. Branton;Jeffrey B. Kopp

  • MYH9 is a major-effect risk gene for focal segmental glomerulosclerosis

    Jeffrey B Kopp;Michael W Smith;George W Nelson;Randall C Johnson

  • Apoptosis in podocytes induced by TGF-β and Smad7

    Mario Schiffer;Markus Bitzer;Ian S.D. Roberts;Jeffrey B. Kopp

  • APOL1 Risk Variants, Race, and Progression of Chronic Kidney Disease

    Afshin Parsa;W. H Linda Kao;Dawei Xie;Brad C. Astor

  • CD2-associated protein haploinsufficiency is linked to glomerular disease susceptibility.

    Jeong M. Kim;Hui Wu;Gopa Green;Cheryl A. Winkler

  • Natural history of Fabry renal disease: influence of alpha-galactosidase A activity and genetic mutations on clinical course.

    Mary H Branton;Raphael Schiffmann;Sharda G Sabnis;Gary J Murray

  • Transgenic mice with increased plasma levels of TGF-beta 1 develop progressive renal disease.

    Jeffrey B. Kopp;Valentina M. Factor;Miklos Mozes;Peter Nagy

  • Metabolomics Reveals Signature of Mitochondrial Dysfunction in Diabetic Kidney Disease

    Kumar Sharma;Bethany Karl;Anna V. Mathew;Jon A. Gangoiti

  • Rapid isolation of urinary exosomal biomarkers using a nanomembrane ultrafiltration concentrator.

    Anita Cheruvanky;Hua Zhou;Trairak Pisitkun;Jeffrey B. Kopp

  • The Notch pathway in podocytes plays a role in the development of glomerular disease

    Thiruvur Niranjan;Bernhard Bielesz;Antje Gruenwald;Manish P Ponda

  • Research capacity. Enabling the genomic revolution in Africa

    Charles Rotimi;Akin Abayomi;Alash'le Abimiku;Victoria May Adabayeri

  • Crystalluria and Urinary Tract Abnormalities Associated With Indinavir

    J.B. Kopp;K.D. Miller;J.A.M. Mican;I.M. Feuerstein

  • Twenty-one-year trend in ESRD due to focal segmental glomerulosclerosis in the United States

    Chagriya Kitiyakara;Paul Eggers;Jeffrey B. Kopp

  • Association of Trypanolytic ApoL1 Variants with Kidney Disease in

    Giulio Genovese;David J. Friedman;Michael D. Ross

Frequent Co-Authors

Cheryl A. Winkler
Cheryl A. Winkler National Institutes of Health
Barry I. Freedman
Barry I. Freedman Wake Forest University
Martin R. Pollak
Martin R. Pollak Beth Israel Deaconess Medical Center
Carl D. Langefeld
Carl D. Langefeld Wake Forest University
Marguerite R. Irvin
Marguerite R. Irvin University of Alabama at Birmingham
Lawrence B. Holzman
Lawrence B. Holzman University of Pennsylvania
Mary Cushman
Mary Cushman University of Vermont
Donald W. Bowden
Donald W. Bowden Wake Forest University
Matthias Kretzler
Matthias Kretzler University of Michigan–Ann Arbor

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a career in medicine doesn’t always require the traditional path of medical school. Many students explore related degrees and alternative healthcare roles that can be started quicker and sometimes with fewer requirements. For example, those with a non-nursing background can consider direct entry msn programs online which offer a fast-track into advanced nursing careers.

If you’re seeking an accessible route, some schools offer the easiest bsn program to get into, allowing you to begin your nursing education without the highly competitive admissions process. Alternatively, entering the healthcare field as a medical coder is another viable pathway. Many medical billing and coding schools that accept financial aid provide flexible learning options and financial support.

For licensed practical nurses, advancing their careers is also possible through lpn to rn programs without teas test, which streamline the transition to registered nursing roles. This diversity of degree and career opportunities makes it easier than ever to join the healthcare workforce and find a path suited to your interests and circumstances.

Best Scientists Citing Jeffrey B. Kopp

Trending Scientists